Skip to Main text

Taiwan

Press Release 2019

Select Category
2019/Dec/03
Establishment of the Tokyo Head Office and Consolidation with the Tokyo Sales Branch
2019/Nov/29
「令和元年台風第19号」に対する支援について
2019/Jul/19
Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”)
2019/Jun/18
Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN™ Tape in Japan
2019/Jun/07
Launch of Bisono™ Tape 2mg, a Transdermal Patch Containing a β1 Blocker
2019/Apr/18
Established a Collaborative Research Department for the Development of New Nucleic Acid Drugs
2019/Feb/27
The Nitto ATP Finals charitable activities in support of UNICEF
2019/Jan/23
Nitto Named One of 2018-19 Derwent Top 100 Global Innovators, Marking its Eighth Consecutive Year on the List
2019/Jan/08
Additional Approvals for Bisono™Tape, a Transdermal Patch containing a β1Blocker, for Atrial Fibrillation, for a 2 mg strength and for improved formulations of 4 mg and 8 mg strengths in Japan
  • topics
  

Contact Us

Business Hours(Taiwan time)
8:30-17:30 (Except for Sat, Sun, and Holidays)

Related Information

Back to Page Top